Important Safety InformationUVADEX® (methoxsalen) Prescribing InformationHealthcare Professionals

Follow us:

en-US flag

English

  • language flag

    English

  • language flag

    German

  • language flag

    Italian

  • language flag

    Spanish

THERAKOS Photopheresis logo, representing advanced medical treatment.
Languages:

UVADEX® (methoxsalen) Sterile Solution is used with the THERAKOS CELLEX® Photopheresis System for the treatment of skin problems associated with cutaneous T-cell lymphoma (CTCL) in patients who have not responded to other types of treatment prescribed by their doctor.

Patient Stories

Patient Stories Hero Updated

Featured patients have been compensated for sharing their stories. Results may vary.
The health status of the patient in the video reflects his or her condition at the time the video was recorded and may have changed over time.

Shelia stayed positive during treatment

  • Diagnosed with CTCL 6 years after skin symptoms first appeared
  • After a difficult journey to diagnosis of her CTCL skin symptoms, Shelia experienced a series of challenges that tested her to the core. But she found support from those around her and knows the value in giving back to the CTCL community
Image of Sheila - a THERAKOS patient from her patient stories video.

Anita took action

  • Diagnosed with CTCL 10 years after skin symptoms first appeared
  • Anita first noticed a persistent rash as she was helping her daughter train for a marathon. She knew she needed to become her own best advocate to find a diagnosis and treatment for her CTCL skin symptoms
Image of Anita - a THERAKOS patient from her patient stories video.

Ann searched for answers

  • Diagnosed with CTCL 40 years after skin symptoms first appeared
  • After Ann learned more about her skin symptoms of CTCL, she stopped feeling like she needed to hide her condition and started being her own best advocate
Image of Ann - a THERAKOS patient from her patient stories video.

Kris researched her options

  • Diagnosed with CTCL 11 years after skin symptoms first appeared
  • Kris has said that CTCL can be life changing to patients and their families. Kris was more focused on her 2 young boys than her health before her diagnosis. Afterward, Kris has tried to be her own health advocate
Image of Kris - a THERAKOS patient from her patient stories video.

Lou focused on progress

  • Diagnosed with CTCL 25 years after skin symptoms first appeared
  • Lou was hopeful about photopheresis after trying a few other treatments but still struggling with CTCL skin symptoms
Image of a male THERAKOS patient from their patient video.
Watch the video and listen to Lou’s experience with THERAKOS® Photopheresis.

Kristi’s Journey to her CTCL Skin Symptoms Diagnosis

  • Diagnosed with CTCL 10 years after her skin symptoms first appeared

  • Entering a world full of unknowns with her diagnosis, Kristi tamed her fears by seeking out as much information as possible about CTCL skin symptoms. Now, she wants to be a patient who helps others as they begin their treatment journeys

Kristi (1)
Watch the video and listen to Lou’s experience with THERAKOS® Photopheresis.

Want to share your story?

Sharing your experiences with skin symptoms of CTCL and THERAKOS® Photopheresis may help others feel connected. Your story may encourage others to take an active role in their treatment, reach out to their doctors, and find a treatment option. If you’d like to share your story, Mallinckrodt would like to hear from you.

 

To learn more and find out if you may be eligible to participate in promotional and educational activities, please call: 1-844-514-6288.

Patient Group Hero Updated

Discover more

THERAKOS® Photopheresis therapy

Discover More

Find a treatment center

Discover More

Find a CTCL community near you

Discover More

The information below is about the use of UVADEX® (methoxsalen) Sterile Solution with the THERAKOS CELLEX® Photopheresis System for the treatment of skin conditions associated with Cutaneous T-Cell Lymphoma (CTCL) unresponsive to other types of treatment.


It is recommended that you discuss the therapy and your conditions with your doctor.


What is UVADEX (methoxsalen [meth-ox-sah-len]) Sterile Solution?

UVADEX (methoxsalen) Sterile Solution is used with the THERAKOS CELLEX Photopheresis System for the treatment of skin problems associated with CTCL in patients who have not responded to other types of treatment given by their doctor.

IMPORTANT SAFETY INFORMATION

UVADEX (methoxsalen) Sterile Solution should only be used by doctors who have special skills in the diagnosis and treatment of CTCL and who have received special training and have experience in the THERAKOS CELLEX Photopheresis System.

DO NOT USE UVADEX IF:

  • You are allergic to methoxsalen, any product similar or related to it, such as psoralen, or any of the other ingredients in UVADEX.
  • You have a history of a light-sensitive condition or disease.
  • You have had an eye lens removed; use of UVADEX in this condition can increase the risk of retinal damage.

WARNINGS

  • You may be at greater risk of sun sensitivity with UVADEX. Tell your doctor if you are taking other medications that cause sensitivity to sunlight, such as anthralin, coal tar or coal tar derivatives, griseofulvin, phenothiazines, nalidixic acid, halogenated salicylanilides (bacteriostatic soaps), sulfonamides, tetracyclines, thiazides, and certain organic staining dyes, such as methylene blue, toluidine blue, rose bengal, and methyl orange.
  • If you are pregnant or plan to become pregnant, tell your doctor. Methoxsalen can harm your unborn baby. Tell your doctor right away if you become pregnant during your UVADEX treatment. If you are breastfeeding or plan to breastfeed, tell your doctor. It is not known if methoxsalen passes into your breastmilk.
  • After UVADEX is given, exposure to sunlight and/or ultraviolet radiation may result in premature aging of your skin.
  • Let your doctor know if you currently have skin cancer or if you had skin cancer in the past.
  • If you are given too much UVADEX, you may get serious burns from UVA or sunlight (even through window glass).
  • Avoid exposure to sunlight during the 24 hours after treatment.
  • Exposure to UVA light when UVADEX is used can cause cataract formation if proper eye protection is not used.
  • You must wear UVA light-absorbing, wrap-around sunglasses for the 24 hours after treatment with UVADEX when you are exposed to direct or indirect sunlight, whether you are outdoors or exposed through a window.
  • If you are being treated for Graft vs Host Disease (GVHD), consult your physician for information regarding blood clots involving the lung and other parts of the body which have been reported in these patients. The use of UVADEX for the treatment of GVHD is not approved by the FDA.
  • Safety of UVADEX in children has not been shown.

SIDE EFFECTS OF UVADEX

  • Side effects of UVADEX used with the THERAKOS Photopheresis System are mainly related to low blood pressure.

For the THERAKOS CELLEX Photopheresis System procedure:

What is the THERAKOS Photopheresis System procedure?

The THERAKOS CELLEX Photopheresis System procedure is a medical procedure in which blood from a patient is collected into a specialized machine that separates the white blood cells from the other blood components. The other blood components are returned to the patient and white blood cells are then treated with UVADEX, which makes them sensitive to ultraviolet light. The treated white blood cells are exposed to UVA irradiation inside the machine, and then returned to the patient. This medical procedure is used to treat skin problems associated with CTCL in patients who have not been responsive to other forms of treatment given by their doctor.


DO NOT UNDERGO THE THERAKOS PHOTOPHERESIS SYSTEM PROCEDURE IF:

  • You have a condition that makes you unable to tolerate loss of blood volume.
  • You are allergic or hypersensitive to 8-methoxypsoralen, methoxsalen, or psoralen compounds.
  • Your doctor has diagnosed you with a blood-clotting or bleeding problem that can lead to either a blood clot or excessive bleeding.
  • You have had your spleen removed.

WARNINGS FOR THE THERAKOS PHOTOPHERESIS SYSTEM PROCEDURE

  • Treatments with THERAKOS Photopheresis System should always be performed where standard medical emergency equipment is available.
  • THERAKOS Photopheresis System procedures should not be performed on the same day as procedures that can cause fluid changes, such as renal dialysis.

SIDE EFFECTS OF THE THERAKOS PHOTOPHERESIS SYSTEM PROCEDURE

  • Low blood pressure can occur with the THERAKOS Photopheresis System procedure.
  • You may get an infection and/or feel pain at the site of injection.
  • Fevers of 100–102°F (37.7–38.9°C) have been seen in some patients within 6 to 8 hours after treatment. Redness of the skin may also occur with the fever.
  • A decrease in red blood cells can occur if the THERAKOS Photopheresis System procedure is given too frequently. Low levels of red blood cells may cause you to feel tired.

These are not all of the possible side effects of the THERAKOS Photopheresis System procedure.


Tell your doctor about any side effects that bother you, or that do not go away. Call your doctor or pharmacist for medical advice about side effects. You may report side effects to the FDA.Call 1-800-FDA-1088 or visit www.fda.gov/medwatch. You may also report side effects by calling Mallinckrodt at 1-877-566-9466.


Please see the full Prescribing Information, including the BOXED WARNING, for UVADEX.

IMPORTANT SAFETY INFORMATION
chevron-up chevron-down

UVADEX (methoxsalen) Sterile Solution should only be used by doctors who have special skills in the diagnosis and treatment of CTCL and who have received special training and have experience in the THERAKOS CELLEX Photopheresis System.

Thank you for visiting patient.Therakos.com

You are about to leave a Mallinckrodt site. Mallinckrodt does not control or endorse the content on the site you are about to view.